What Is Under Investors’ Radar – RHT, FBR And LYC

The stock markets in Australia were pushed below 5600 levels amid heavy selling, US-China trade dispute continuing and all sectors closing in red on Monday, December 10, 2018. With the European and US markets down, the Australian markets closed slightly higher after the Brexit chaos. Under such circumstances, few stocks are falling under investor’s radar.

One stock which was helped by the rebounding of the healthcare sector is RESONANCE HEALTH LIMITED (ASX: RHT) which went up by as much as 27.632% and traded at $0.097 which is close to its 52-week high. Resonance has a very high P/E of 126.670 and EPS of 0.001 AUD which reflects the future growth of the company. The recent increase in the price of the company’s securities and the volumes of securities traded was clarified to ASX by the company. The company has increased its market penetration for existing core products; there is an increase in revenue of 17% versus the previous financial year to $2.91 million. Cash at financial year end was of $1.55m, and the company has no debt reflecting a strong balance sheet. For, FY 2017/18 including employee share-based payments, the company reported a net profit after tax of $224,619.   

Another stock from the industrials sector which is gaining traction is FBR LTD (ASX: FBR) which has gone up by 4.348% to $0.120 and is quite near to its 52-week low. The company FBR will enable brick and block manufacturers to deliver walls on demand for their customers with its new commercial model for the Hadrian X known as Wall as a Service™, or WaaS™. The company’s MOU with CAT has been discontinued and is free to discuss opportunities regarding DST and Hadrian X technology and supply with interested parties. The company has a cash reserve of $21.7 million as at September 30, 2018, and the gross assets on June 30, 2018, were at $46.5 million.

From the metals and mining sector, LYNAS CORPORATION LIMITED (ASX: LYC) traded lower at $1.655 down by 0.898% on the day which is close to its 52-week low. The stock has a P/E of 18.890 and EPS of 0.088 AUD which is decent when compared to its peer basket. The company provided the report of the Review Committee into Lynas Malaysia’s operations, and it was found that the operations are low risk and compliant with applicable laws. The company is a proven and profitable producer of specialty Rare Earth Materials with the cash balance of A$65.8 million as at September 30, 2018. Over the years Lynas’s NEXT growth project improved its cash position and improved debt, with A$ 118.5 million operating cash flow and the US $165 million in debt respectively.

forward

Forward P/E for RHT, FBR, LYC, Source: Thomson Reuters


Disclaimer

This website is a service of Kalkine Media Pty. Ltd. A.C.N. 629 651 672. The website has been prepared for informational purposes only and is not intended to be used as a complete source of information on any particular company. Kalkine Media does not in any way endorse or recommend individuals, products or services that may be discussed on this site. Our publications are NOT a solicitation or recommendation to buy, sell or hold. We are neither licensed nor qualified to provide investment advice.

Join Our Discussion

Start discussion with value Investors for ASX Stock Market Investment and Opinion.


6 Cannabis Stocks under Investor’s Limelight…

Cannabis companies that sell both medicinal weed and recreational pot. Marijuana stocks to look at. Marijuana mergers and acquisitions. Dispensary data analytics. Upcoming marijuana IPO’s Those phrases have become increasingly common as marijuana legalization spreads.

Global spending on legal cannabis is expected to grow 230% to $32 billion in 2020 as compared to $9.5 in 2017, according to Arcview Market Research and BDS Analytics. As of June 29, 2018 the United States Marijuana Index, despite a lot of uncertainty around regulations, has over the past 1 year gained 71.49%, as compared to about 12% gain seen by the S&P 500.

Click here for your FREE Report